Gateway2UK: UK Market Entry Programme in Early Cancer Diagnostics
Seeking innovative solutions to help improve the speed and accuracy of cancer detection for the NHS in England.
Nearly 3.5 million people are living with cancer in the UK, due to rise to 4 million by 2030. Early cancer diagnosis is a national priority for the National Health Service (NHS) in England, which has set an aim to diagnose 75% of cancers in the early stages by 2028.
We are looking for innovative solutions to help improve the speed and accuracy of cancer detection, enabling patients to receive effective treatment faster.
Are you an international public or private sector organisation that support innovative companies to access opportunities in other markets?
This high-impact 2-day programme is focused on addressing the unmet needs within the NHS, providing valuable insights into the UK healthcare system and the opportunities and challenges of introducing, adopting, and scaling cancer innovations within the NHS, as well as exceptional networking opportunities.
Participating companies will experience a focused, high-calibre learning environment giving forward-thinking teams a unique opportunity to navigate the complexities of the UK healthcare ecosystem. Guided by NHS executives, industry leaders, and investors, this programme is a catalyst for strategic partnerships and growth in the UK market, all tailored to help businesses position their innovation for success in the UK.
Set in a vibrant location with breathtaking views of St. Paul’s Cathedral, Gateway2UK is limited to a maximum of 20 participants, ensuring a tailored approach and in-depth discussions. The programme promises a focused, personalised experience, fostering high-quality interactions and providing actionable insights.
Gateway2UK programme will provide:
- A clearer understanding of the UK healthcare landscape, opportunities and initiatives in the cancer sector
- Valuable connections with potential partners and investors active in healthcare innovation
- A strategic roadmap for setting up operations in the UK and accelerating market entry
Agenda
The 2-day programme will see speakers from both Gateley Global and Health Innovation East, consisting of various topics including but not limited to;
- The UK Health Innovation landscape and key trends
- Navigating the NHS: Roadmap and Strategic Priorities with a Focus on Cancer Care
- Breakthrough to the UK Market: Getting it right first time
- Unlocking Funding Opportunities and UK Tax reliefs
- Developing your Value Proposition
- Budget Impact Models and Health Economics
- Mastering your Pitch Workshop
- Regulatory and Market Entry Requirements
- Procurement Pathways in the UK Healthcare Industry
- Innovator's Success Story: Collaborative Learning Reflections/Landing and Navigating the New Market
- Demo Day: Test Your Innovation
- Investor's Night: Exclusive dinner with industry investors
For detailed information on the agenda over the 2-day programme, please visit Health Innovation East
About the organisers
Health Innovation East
Part of the Health Innovation Network - The innovation arm of the NHS
Great ideas only make a difference for our health when they are put into practice. Whether we are working with global companies, pioneering startups, universities or health providers we help the best innovations in health and care reach the people, places and problems where they deliver most benefit. As the regional innovation arm of the NHS our team includes healthcare professionals, specialist technologists and commercial advisors; our collective skill set is at the forefront of the advances being made across health and care.
Health Innovation East is ideally positioned to deliver both bespoke individual projects and large complex programmes from concept through to implementation. Within the Eastern region, we have strong working relations with:
- Six integrated care boards, encompassing acute, community, mental health and primary care providers of healthcare
- Six universities, including University of Cambridge (UoC) Anglia Ruskin University (ARU), University of East Anglia (UEA), University of Essex
- Research parks, including Cambridge Biomedical Campus, Norwich Research Park, Babraham Research Park and the Wellcome Genome Campus.
For more information, visit Health Innovation East.
Gateley Global
Gateley Global is an award-winning, new market entry and economic development consultancy specialising in all aspects of international trade and investment, with expertise spanning both the public and private sector. Our multinational team possesses over 100 years cumulative experience supporting international companies entering new markets as well as designing and delivering market entry and investment programmes for some of the most successful International Promotional Agencies in the world.
We understand the challenges that companies face when expanding into new markets, and we provide a project management and roadmap service to explain to companies the specific steps and timeframes associated to successfully and efficiently operate in new, global markets. We also are well aware of the challenges faced by Government Organisations and Trade and Investment Promotion agencies to ensure the delivery of impactful trade and investment initiatives across their regions in order to drive sustainable economic growth for their communities.
Gateley Global provides tailored solutions and services to help International Promotional Agencies at all geographic scales and stages to overcome increasing global competition, enabling our clients to deliver more to companies whilst facing resource constraints.
FAQs
To find out more about this programme and if it is right for your organisation, please read our FAQs.
Public or private sector organisations that support innovative companies in the life sciences and healthcare industry to access opportunities in international markets, including life sciences and healthcare clusters, international trade and investment organisations, investors and venture capital firms with investment portfolios in the industry, amongst others.
Businesses participating in the programme through the above-mentioned organisations must have a proven track record in early cancer diagnostics, and an interest in expanding into the UK healthcare market.
- In-depth market insights
To gain a comprehensive understanding of the UK healthcare ecosystem, guided by industry experts and NHS leaders who are well-versed in the unique challenges and opportunities of introducing and adopting early cancer diagnostic innovations in the NHS. - Engage with key decision-makers
To connect with a curated group of UK-based investors, NHS ICS leads, representatives from the Cancer Alliances, and experts in regulatory affairs and intellectual property, building essential relationships for future collaboration. - Value proposition workshop and pitching opportunity
To discover how to effectively communicate the unique benefits of the participants’ innovation and adapt their pitch for different stakeholders followed by an opportunity to pitch your business in front of a panel of key stakeholders and investors, receiving valuable feedback and increasing your chances of securing future partnerships and funding. - Exclusive networking night with investors
To solidify new connections and explore investment opportunities in a relaxed social setting designed to foster meaningful partnerships.
With only 20 spaces available, participants will benefit from a highly-personalised experience designed to foster valuable connections and actionable insights, paving the way for successful partnerships.
This 2-day programme can be delivered at any time throughout the year and adapted to clients’ needs. The organisers, Gateley Global and Health Innovation East, will be delighted to discuss potential dates and timeframe requirements to deliver this programme for your organisation.
Be a part of Gateway2UK programme for early cancer diagnosis
Express your interest in Gateway2UK by completing the form below.